RT Journal Article
SR Electronic
T1 474 Intratumoral CTLA-4-targeting INTASYL™ self-delivering RNAi enhances tumor control in combination with systemic anti-PD-1 antibody therapy in vivo suggesting a strategy to mitigate irSAEs
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A533
OP A533
DO 10.1136/jitc-2023-SITC2023.0474
VO 11
IS Suppl 1
A1 Cuiffo, Benjamin
A1 Yan, Dingxue
A1 Boone, Andrew
A1 Rivest, Brianna
A1 Maxwell, Melissa
A1 Cardia, James
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A533.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.